A Biomarker for Parkinson’s
The Scotsman newspaper reports today (29 August, 23016) that scientists are a step closer to developing a test for early-stage Parkinson’s. Research has shown that a molecule linked to the…
Read article
Research news
New finding about alpha synuclein
Science Today reports that researchers at the University of Pittsburgh School of Medicine have uncovered a major reason why the Parkinson’s-related protein alpha-synuclein, a major constituent of the Lewy bodies…
Transplanted Nerve Cells Survive for 25 Years
In the late 1980s and over the 1990s, researchers at Lund University in Sweden pioneered the transplantation of new nerve cells into the brains of patients with Parkinson’s disease. The…
FDA approves new Parkinson’s psychosis drug
The Michael J Fox Foundation (MJFF) reports today that Nuplazid has become the first medication approved for Parkinson’s psychosis (hallucinations and delusions). Previously available psychosis medications worked on both the…
Structure of alpha synuclein fibrils exposed
University of Illinois chemists, collaborating with peers at the University of Pennsylvania, Vanderbilt University and Queen Mary University of London, detailed their mapped structure of the protein alpha synuclein, in…
Fungicide linked to neurodegenerative conditions
The 31 March issue of Science Daily reports that scientists at the University of North Carolina School of Medicine have found a class of commonly used fungicides that produce gene…